FDA Approval

Devices & Diagnostics

Beyond the hype of the FDA’s approval of the first bionic eye

It’s easy to get excited when really intriguing and previously unthinkable technology reaches the marketplace. For example, there’s been a lot of hype in the news leading up to the U.S. Food and Drug Administration’s announcement today that it approved Second Sight Medical’s Argus II Retinal Prosthesis system — the world’s first bionic eye. The […]

Devices & Diagnostics

FDA clears Conventus Orthopaedics’ less invasive treatment to repair wrist fractures

Minnesota orthopaedics device startup Conventus Orthopaedics announced Monday that the U.S. Food and Drug Administration has approved its minimally invasive treatment for repairing wrist fractures. The Conventus Distal Radius Surgical System is a self-expanding implant that requires small incisions and is able to reduce “surgical trauma by as much as 80 percent compared to traditional […]

Devices & Diagnostics

FDA clears ablation treatment that gynecologists can use to treat uterine fibroids in women

Halt Medical, a medical device company based in Brentwood, California, announced Tuesday that the Food and Drug Administration has cleared its Acessa device that gynecologists can use to treat female uterine fibroids. The device uses RF ablation to treat just the fibroids and is an alternative to traditional fibroid surgery where “layers of healthy tissue […]

Devices & Diagnostics

Utah startup Amedica gets FDA clearance for interbody spinal fusion device system

Salt Lake City, Utah-based Amedica announced Thursday that it has received regulatory clearance for the second generation of an interbody fusion device system. The U.S. Food and Drug Administration has cleared its cervical and lumbar interbody fusion devices (IBF) made with a proprietary biomaterial. These devices and their design improvements will help surgeons perform minimally invasive […]

presented by
Devices & Diagnostics

Subsidiary of Depuy Synthes receives FDA approval for implantable device that treats spasticity

Codman & Shurtleff Inc., part of the Depuy Synthes companies, announced Tuesday that it has received a premarket approval from the U.S. Food and Drug Administration to market a neuromodulation product that treats spasticity. The MedStream Programmable Infusion System is an implanted device that can deliver antispasm drug baclofen directly into the spinal canal through […]

MedCity Influencers

CE mark or FDA approval? Medical device professionals weigh in

With the ever-increasing stringency, time, and expense associated with FDA approval for medical devices, debate is sharpening in the medical devices industry over whether it is actually better business strategy to prioritize getting a CE mark for your product. This article gives an overview of a recent iteration of a robust debate within the Medical […]